Matches in Nanopublications for { ?s ?p "[Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP273841.RAA35YB0awsayKAlh0mYd97GUMmkjvN9lv7eJzk2z8yyo130_assertion description "[Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273841.RAA35YB0awsayKAlh0mYd97GUMmkjvN9lv7eJzk2z8yyo130_provenance.
- NP273817.RA-wL4OmLW-d74lxxMIyRtQ6UYm2H2Alyq8THqVubRyHg130_assertion description "[Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273817.RA-wL4OmLW-d74lxxMIyRtQ6UYm2H2Alyq8THqVubRyHg130_provenance.
- NP273838.RAx0zjnJgi2tdtqK1nFbG-XVPAKdYrBbKAQ7aFo_Ui4KU130_assertion description "[Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP273838.RAx0zjnJgi2tdtqK1nFbG-XVPAKdYrBbKAQ7aFo_Ui4KU130_provenance.
- NP917730.RAeNQYA_E-MmFpz1rplzNvuUA-3N67dUFf1e90sq4iGVg130_assertion description "[Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917730.RAeNQYA_E-MmFpz1rplzNvuUA-3N67dUFf1e90sq4iGVg130_provenance.
- NP917717.RA5CR_r1hjp726hqJREiT_qXIYPSUaky4gjeZUV3_9mMY130_assertion description "[Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917717.RA5CR_r1hjp726hqJREiT_qXIYPSUaky4gjeZUV3_9mMY130_provenance.
- NP917728.RAzsnPut4uSCU9jwOjv8UatmW-B1TInb35idmMZU5IaJE130_assertion description "[Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917728.RAzsnPut4uSCU9jwOjv8UatmW-B1TInb35idmMZU5IaJE130_provenance.
- NP829382.RATb8aTcWkiU0Fnuu5IjKfj-fzaGcp8KXo_uGJFphVQX8130_assertion description "[Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829382.RATb8aTcWkiU0Fnuu5IjKfj-fzaGcp8KXo_uGJFphVQX8130_provenance.
- assertion description "[Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP829380.RAueKpgOGDKLAh3ygoqaUnliVC8g3_0FI_0i9ZT-6vBqo130_assertion description "[Frequent activation of BRF2 in >35% preinvasive bronchial carcinoma in situ, as well as in dysplastic lesions, provides evidence that BRF2 expression is an early event in cancer development of this cell lineage.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP829380.RAueKpgOGDKLAh3ygoqaUnliVC8g3_0FI_0i9ZT-6vBqo130_provenance.